GFAP Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)

N° du produit ABIN2721841

Détail du produit

Antigène: GFAP (Glial Fibrillary Acidic Protein (GFAP))

Type de proteíne: Recombinant

Attributs du protein: Transcript Variant 1

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette GFAP protéine est marqué à la Myc-DYKDDDDK Tag.

Application: Antibody Production (AbP), Standard (STD)

Attributs du produit:

• Recombinant human GFAP (transcript variant 1) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Détail du antigène

Antigène: GFAP (Glial Fibrillary Acidic Protein (GFAP))

Autre désignation: Gfap (GFAP Produits)

Synonymes: GFAP Protein, AI836096 Protein, cb345 Protein, etID36982.3 Protein, gfapl Protein, wu:fb34h11 Protein, wu:fk42c12 Protein, xx:af506734 Protein, zgc:110485 Protein, glial fibrillary acidic protein Protein, GFAP Protein, LOC100136168 Protein, gfap Protein, Gfap Protein

Sujet: This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms.

Poids moléculaire: 49.7 kDa

NCBI Accession: NP_002046